SCImago Journal & Country Rank
This journal is a member of, and subscribes to the principles of, the Committee on Publication Ethics (COPE)
2017, Volume 33, Number 3, Page(s) 223-227     
[ PDF ] [ Similar Articles ]
DOI: 10.5146/tjpath.2017.01402
The Role of CD34 and D2-40 in the Differentiation of Dermatofibroma and Dermatofibrosarcoma Protuberans
1Department of Pathology, Antalya Training and Research Hospital, Antalya, Turkey
2Mugla Sıtkı Koçman University Faculty of Medicine, Mugla, Turkey
3Izmir Ataturk Training and Research Hospital, Izmir, Turkey
4Department of Plastic and Reconstructive Surgery, Izmir Ataturk Training and Research Hospital, Izmir, Turkey
Keywords: Dermatofibroma, Dermatofibrosarcoma protuberans, CD34, D2-40, Podoplanin

Objective: Dermatofibroma (DF) is a benign fibrohistiocytic tumor whereas dermatofibrosarcoma protuberans (DFSP) has intermediate malignant potential. CD34 is the most commonly used antibody in differentiating these tumors. Various studies have stated the rates of D2-40 expression as 0-50% in DFSPs and 86-100% in DFs. Our aim in this study was to determine the expression of CD34 and D2-40 in DFs and DFSPs and the possible use of D2-40 in the differential diagnosis of these lesions.

Material and Method: This is a retrospective study including 30 DF and 15 DFSP cases which were reevaluated for epidermal changes, the presence of a transmission zone (Grenz zone), infiltration of soft tissues, infiltration pattern and histologic subtypes in addition to cellular pleomorphism, nuclear atypia, and necrosis. A manual immunohistochemistry procedure was performed with D2-40 and CD 34 antibodies using a representative paraffin block.

Results: The average age was 37.36 and 42.86 years in the DF and DFSP cases. The average diameter was 0.9 and 5.03 cm, respectively, for the DFs and DFSPs. There was a significant correlation between the two entities for sex, localization and diameter of the lesion. A significant difference was found between the positivity of CD34 and D2-40 in DFs and DFSPs.

Conclusion: Additional immunohistochemical markers may be needed in DFs with CD34 positivity. Our results showed the additional helpful role of this marker in problematic cases.

[ PDF ] [ Similar Articles ]